BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17465200)

  • 1. LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma.
    Takeda S; Iwai A; Nakashima M; Fujikura D; Chiba S; Li HM; Uehara J; Kawaguchi S; Kaya M; Nagoya S; Wada T; Yuan J; Rayter S; Ashworth A; Reed JC; Yamashita T; Uede T; Miyazaki T
    Anticancer Res; 2007; 27(2):761-8. PubMed ID: 17465200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
    Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
    Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
    Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
    Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Ca2+ removal amplifies TRAIL cytotoxicity toward apoptosis-resistant tumor cells via promotion of multiple cell death modalities.
    Takata N; Ohshima Y; Suzuki-Karasaki M; Yoshida Y; Tokuhashi Y; Suzuki-Karasaki Y
    Int J Oncol; 2017 Jul; 51(1):193-203. PubMed ID: 28560396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells.
    Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
    J Orthop Res; 2010 Jun; 28(6):739-45. PubMed ID: 20041491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation.
    Moon MH; Jeong JK; Seo JS; Seol JW; Lee YJ; Xue M; Jackson CJ; Park SY
    Exp Mol Med; 2011 Mar; 43(3):138-45. PubMed ID: 21297379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of death-associated protein 3 (DAP3) in anoikis.
    Miyazaki T; Shen M; Fujikura D; Tosa N; Kim HR; Kon S; Uede T; Reed JC
    J Biol Chem; 2004 Oct; 279(43):44667-72. PubMed ID: 15302871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-induced apoptosis is independent of the mitochondrial apoptosis mediator DAP3.
    Berger T; Kretzler M
    Biochem Biophys Res Commun; 2002 Oct; 297(4):880-4. PubMed ID: 12359235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins.
    Mirandola P; Sponzilli I; Gobbi G; Marmiroli S; Rinaldi L; Binazzi R; Piccari GG; Ramazzotti G; Gaboardi GC; Cocco L; Vitale M
    Int J Oncol; 2006 Jan; 28(1):127-33. PubMed ID: 16327988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα.
    Shekhar TM; Miles MA; Gupte A; Taylor S; Tascone B; Walkley CR; Hawkins CJ
    Oncotarget; 2016 Jun; 7(23):33866-86. PubMed ID: 27129149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
    Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
    Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of DELE, a novel DAP3-binding protein which is crucial for death receptor-mediated apoptosis induction.
    Harada T; Iwai A; Miyazaki T
    Apoptosis; 2010 Oct; 15(10):1247-55. PubMed ID: 20563667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation.
    Sonnemann J; Trommer N; Becker S; Wittig S; Grauel D; Palani CD; Beck JF
    Cancer Biol Ther; 2012 Apr; 13(6):417-24. PubMed ID: 22313685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
    Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
    Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of phosphorylation sites in mammalian mitochondrial ribosomal protein DAP3.
    Miller JL; Koc H; Koc EC
    Protein Sci; 2008 Feb; 17(2):251-60. PubMed ID: 18227431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
    Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
    Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoxomicin Sensitizes Resistant Osteosarcoma Cells to TRAIL Induced Apoptosis.
    Hanikoglu F; Cort A; Ozben H; Hanikoglu A; Ozben T
    Anticancer Agents Med Chem; 2015; 15(4):527-33. PubMed ID: 25666501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.